Oruka Reports Positive Week 28 ORKA-001 Psoriasis Data
MENLO PARK, Calif. — September 23, 2026 Oruka Therapeutics announced positive Week 28 data from the ongoing EVERLAST-A Phase...
safety
Advertisement
Definium Therapeutics to Present Phase 3 DT120 Data at Psych Congress
NEW YORK — September 10, 2026 Definium Therapeutics, Inc. announced plans to present six posters and an invited oral...
Mapi Pharma Advances Once-Monthly Cariprazine Depot After Positive Phase I/IIa Results
NESS ZIONA, Israel, August 12, 2026 Mapi Pharma Ltd. announced initial clinical results from its ongoing Phase I/IIa study...
Advertisement
